CNCK
Coincheck Group N.V.
There isn't enough reported data to score CNCK yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CNCK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| N/A | |
| N/A |
CNCK's revenue is currently healthy, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CNCK.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CNCK PE Valuation
CNCK has no meaningful PE right now: it lost money over the past year.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CNCK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| Stable | |
| Limited | |
| Low |
Analysts expect CNCK's losses to grow, with revenue declining. However, they disagree widely on these estimates.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
IREN has the edge over CNCK on the outlook, with more favorable revenue and profitability expectations.
CNCK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.06 | +$0.71 |
| Q1 2026 | -$0.09 | +$0.33 |
| Q4 2025 | -$0.00 | -100% |
| Q3 2025 | -$0.76 | -142% |
| Q2 2025 | -$0.77 | -145% |
| Q1 2025 | -$0.42 | -134% |
| Q4 2024 | $0.77 | +1825% |
| Q1 2022 | $16.51 | -60% |
CNCK is still losing money, but far less than before: $0.06 per share over the past year, against $0.77 at its worst in mid-2025.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has the edge over CNCK on earnings, with more consistent year-over-year improvement.
CNCK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $716.6M | +36% |
| Q1 2026 | $750.3M | +4.5% |
| Q4 2025 | $899.2M | +17% |
| Q3 2025 | $834.3M | +89% |
| Q2 2025 | $526.4M | +12% |
| Q1 2025 | $718.2M | +13% |
| Q4 2024 | $771.6M | +108% |
| Q3 2024 | $440.9M | +88% |
CNCK's revenue has grown year over year for 15 quarters in a row: $717M last quarter, up 36% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1.2% | -0.2 points |
| Q1 2026 | -1.2% | -1.1 points |
| Q4 2025 | 0.6% | +13 points |
| Q3 2025 | 0.7% | +0.7 points |
| Q2 2025 | -1% | -1.9 points |
| Q1 2025 | 0% | -2.4 points |
| Q4 2024 | -12% | -14 points |
| Q3 2024 | 0% | +0.3 points |
CNCK has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CNCK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$9.1M | -277% |
| Q1 2026 | -$2.9M | +$9.1M |
| Q4 2025 | $12.2M | +$16.3M |
| Q3 2025 | -$8.5M | -$3.5M |
| Q2 2025 | $5.2M | +11% |
| Q1 2025 | -$12M | -204% |
| Q4 2024 | -$4.1M | -149% |
| Q3 2024 | -$4.9M | -995% |
CNCK's free cash flow was −$8M over the past year, against −$16M the year before. Free cash flow isn't a meaningful measure for financial services companies like CNCK.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CNCK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +41% | +56M shares |
| 1 year | +47% | +61M shares |
| 3 years | +1803% | +182M shares |
| 5 years | +9519% | +190M shares |
CNCK has 192M diluted shares, up 47% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over CNCK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CNCK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 85.4x | High |
| Q1 2026 | -66.8x | Net Cash |
| Q3 2024 | 0.0x | Very low |
| Q2 2024 | -2.5x | Net Cash |
| Q1 2024 | 9.9x | High |
| Q4 2023 | -2,695.0x | Net Cash |
| Q4 2022 | 0.0x | Very low |
| Q3 2022 | -5.3x | Net Cash |
CNCK has the edge over IREN on leverage, with a lower net debt burden relative to earnings.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CNCK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.0 | Neutral |
| Stochastic | 2.8 | Oversold |
CNCK's weekly RSI is 32 (neutral) and its Stochastic is 3 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CNCK PE vs Financial Services Sector
CNCK has no meaningful PE right now: it lost money over the past year.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CNCK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 17% below |
| 20 week MA | $1.85 | 41% below |
| 50 week MA | $2.17 | 49% below |
| 100 week MA | $4.03 | 73% below |
IREN has stronger trend alignment. CNCK is above 0 of 4 weekly averages versus IREN above 1 of 5.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CNCK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $13.9 | $8.50 | -39% |
| 2025 | $8.50 | $3.48 | -59% |
| 2026 YTD | $3.48 | $1.10 | -68% |
CNCK has finished every year since 2024 lower, and it's down 68% so far in 2026.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN has the edge over CNCK on returns for 2026, with the stronger performance.